BR112023026514A2 - Método para preparar um composto [18f] radiomarcado - Google Patents
Método para preparar um composto [18f] radiomarcadoInfo
- Publication number
- BR112023026514A2 BR112023026514A2 BR112023026514A BR112023026514A BR112023026514A2 BR 112023026514 A2 BR112023026514 A2 BR 112023026514A2 BR 112023026514 A BR112023026514 A BR 112023026514A BR 112023026514 A BR112023026514 A BR 112023026514A BR 112023026514 A2 BR112023026514 A2 BR 112023026514A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- radio
- labelled compound
- water content
- radiolabeled compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/007—Steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108605.3A GB202108605D0 (en) | 2021-06-16 | 2021-06-16 | Effect of water content |
| PCT/EP2022/066483 WO2022263594A1 (en) | 2021-06-16 | 2022-06-16 | Method for preparing an [18f] radiolabelled compound with low water content during labelling step |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023026514A2 true BR112023026514A2 (pt) | 2024-03-05 |
Family
ID=76954450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023026514A BR112023026514A2 (pt) | 2021-06-16 | 2022-06-16 | Método para preparar um composto [18f] radiomarcado |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20240366808A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355715A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522770A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021888A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500773A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022294052A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023026514A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223802A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202108605D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308917A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015076A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263594A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0520527D0 (en) | 2005-10-10 | 2005-11-16 | Ge Healthcare Ltd | Automated method |
| EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| AU2011213568B2 (en) | 2010-02-08 | 2016-05-12 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
| EP2657213A1 (en) * | 2012-04-24 | 2013-10-30 | Institut National de la Santé et de la Recherche Medicale | Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors |
| DK2880005T3 (en) * | 2012-07-30 | 2016-07-18 | Univ Denmark Tech Dtu | RADIO FLUOR RING PROCEDURE |
| WO2016086036A2 (en) * | 2014-11-25 | 2016-06-02 | Bristol-Myers Squibb Company | Methods and compositions for 18f-radiolabeling of biologics |
| US10716869B2 (en) * | 2016-02-29 | 2020-07-21 | Oncodesign Sa | Radiolabeled macrocyclic EGFR inhibitor |
| ES2907130T3 (es) * | 2017-09-26 | 2022-04-22 | Inst Nat Sante Rech Med | Darapladib radiomarcado, análogos del mismo y su uso como compuestos para la obtención de imágenes |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
-
2021
- 2021-06-16 GB GBGB2108605.3A patent/GB202108605D0/en not_active Ceased
-
2022
- 2022-06-16 EP EP22734290.4A patent/EP4355715A1/en active Pending
- 2022-06-16 AU AU2022294052A patent/AU2022294052A1/en active Pending
- 2022-06-16 IL IL308917A patent/IL308917A/en unknown
- 2022-06-16 US US18/569,180 patent/US20240366808A1/en active Pending
- 2022-06-16 BR BR112023026514A patent/BR112023026514A2/pt unknown
- 2022-06-16 CN CN202280043075.0A patent/CN117500773A/zh active Pending
- 2022-06-16 CA CA3223802A patent/CA3223802A1/en active Pending
- 2022-06-16 MX MX2023015076A patent/MX2023015076A/es unknown
- 2022-06-16 KR KR1020247001158A patent/KR20240021888A/ko active Pending
- 2022-06-16 WO PCT/EP2022/066483 patent/WO2022263594A1/en not_active Ceased
- 2022-06-16 JP JP2023577714A patent/JP2024522770A/ja active Pending
-
2025
- 2025-06-09 US US19/232,774 patent/US20250312494A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022294052A1 (en) | 2023-12-14 |
| EP4355715A1 (en) | 2024-04-24 |
| MX2023015076A (es) | 2024-01-18 |
| GB202108605D0 (en) | 2021-07-28 |
| KR20240021888A (ko) | 2024-02-19 |
| IL308917A (en) | 2024-01-01 |
| US20250312494A1 (en) | 2025-10-09 |
| CA3223802A1 (en) | 2022-12-22 |
| WO2022263594A1 (en) | 2022-12-22 |
| JP2024522770A (ja) | 2024-06-21 |
| US20240366808A1 (en) | 2024-11-07 |
| CN117500773A (zh) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013033837A2 (pt) | retardante de cimento e processo de utilização do mesmo | |
| BR112014009009A2 (pt) | método melhorado de tratamento de água com dióxido de cloro | |
| BRPI0822183A2 (pt) | Processo para redução do teor de lementos tais como boro em halogenossilanos, bem como instalacões para realização do processo | |
| AR115297A1 (es) | Método para concentración y purificación de eluato de salmuera para la producción de un compuesto de litio purificado | |
| BR112014017585A8 (pt) | processo para produção de hexametileno diamina a partir de materiais contendo carboidrato e intermediários para os mesmos | |
| EA202092139A2 (ru) | Способы производства сульфата калия и хлорида натрия из сточных вод | |
| EP2749565A4 (en) | GLYCOSIDE COMPOUND, METHOD FOR THE PRODUCTION OF THIOETHERS, ETHER, METHOD FOR THE PRODUCTION OF, ETHER, METHOD FOR THE PRODUCTION OF A GLYCOSIDE COMPOUND, PROCESS FOR THE PREPARATION OF A NUCLEIC ACID | |
| MY184911A (en) | Method for producing aei zeolite | |
| BR112014014062A2 (pt) | produção de 1,3-dienos por conversão enzimática de 3- hidroxialc-4-enoatos e/ou 3-fosfonoxialc-4-enoatos | |
| BR112019002417A2 (pt) | cristalização de glicosídeos de esteviol | |
| BR112023024667A2 (pt) | Processo para tratamento de um sulfato de sódio que contém corrente de processo de resíduos de uma instalação de produção de bateria, uma instalação de reciclagem de bateria ou uma usina de produção de aço | |
| BR112012019011A2 (pt) | "processo para fazer zeólito de titânio- mww". | |
| BR112014018044A8 (pt) | Processo para preparação de sílicas precipitadas | |
| TN2015000372A1 (en) | A method for concentrating rare-earth metals in phosphogypsum | |
| BR112014014648A8 (pt) | catalisador para a síntese de mercaptanos de alquila e processo para a sua produção | |
| NZ597315A (en) | Environmentally-friendly cementitious articles, formulations, methods of making and uses | |
| BR112018070701A2 (pt) | processo para destilação de uma mistura de aldeídos. | |
| BR112015021526A2 (pt) | produção de ácido fosfórico por um processo de cristalização em dois estágios | |
| CN104557517B (zh) | 一种废柠檬酸钠母液综合处理工艺 | |
| BR112015013021A2 (pt) | método para a produção de sal mineral e produtos com sal mineral | |
| AR068520A1 (es) | Proceso para la produccion de sulfato de sodio e hidroxido de magnesio | |
| BR112012008030A2 (pt) | processo para a purificação de uma corrente aquosa proviniente da reação fischer-tropsch | |
| FR3062851B1 (fr) | Procede de preparation monotope de composes organo-iodes | |
| BR112022015754A2 (pt) | Processo para a síntese de s-beflubutamid a partir do ácido (r)-2-aminobutanoico | |
| BR112015014801A2 (pt) | processo de produção de oligossacarídeos, a partir de biomassa lignocelulósica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |